Literature DB >> 7903200

Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.

T Zordan-Nudo1, V Ling, Z Liu, E Georges.   

Abstract

Multidrug-resistant cells are thought to maintain low intracellular cytotoxic drug concentration though the active efflux of drugs across the cell membrane. It is presently believed that P-glycoprotein mediates this energy-dependent drug efflux by interacting directly with various lipophilic compounds. In this report, we have used [3H]azidopine in a photoaffinity labeling assay to study the effect of detergents and denaturing agents on P-glycoprotein drug binding in intact cells. Nonionic detergents such as Triton X-100 or Nonidet P-40 at very low concentrations were found to completely abolish azidopine photolabeling to P-glycoprotein and are able to reverse the multidrug resistance phenotype. In contrast, high concentrations of the denaturing agent urea or the zwitterionic detergent 1-[(3-cholamidopropyl)dimethylamino]-1-propanesulfonate did not inhibit azidopine photolabeling to P-glycoprotein. A comparison between verapamil and Triton X-100 revealed that the latter was more effective in inhibiting azidopine photolabeling to P-glycoprotein while verapamil was more effective in potentiating [3H]vinblastine accumulation in drug-resistant cells. Drug transport studies showed that [3H]Triton X-100 accumulated in both drug-sensitive and -resistant cells, and its accumulation was not modulated by excess vinblastine, verapamil, or colchicine. Taken together, these findings suggest that low concentrations of Triton X-100 reverse the multidrug resistance phenotype by inhibiting P-glycoprotein drug binding. In addition, it is also suggested that the site(s) of P-glycoprotein drug binding is localized to sequences found within the lipid bilayer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903200

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Anti-inflammatory efficacy of dexamethasone and Nrf2 activators in the CNS using brain slices as a model of acute injury.

Authors:  David J Graber; William F Hickey; Elijah W Stommel; Brent T Harris
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-17       Impact factor: 4.147

2.  The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.

Authors:  M M Nerurkar; P S Burton; R T Borchardt
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

Review 3.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers.

Authors:  Carol L Roberts; Asa V Keita; Sylvia H Duncan; Niamh O'Kennedy; Johan D Söderholm; Jonathan M Rhodes; Barry J Campbell
Journal:  Gut       Date:  2010-09-02       Impact factor: 23.059

Review 5.  Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs.

Authors:  Saba Khan; Sanjula Baboota; Javed Ali; Sana Khan; Ramandeep Singh Narang; Jasjeet Kaur Narang
Journal:  Int J Pharm Investig       Date:  2015 Oct-Dec

Review 6.  Intestinal lymphatic transport for drug delivery.

Authors:  Jaime A Yáñez; Stephen W J Wang; Ian W Knemeyer; Mark A Wirth; Kevin B Alton
Journal:  Adv Drug Deliv Rev       Date:  2011-06-13       Impact factor: 15.470

7.  Strategies for enhanced drug delivery to the central nervous system.

Authors:  V S N M Dwibhashyam; A N Nagappa
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

Review 8.  Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function.

Authors:  Frances Jane Sharom
Journal:  Front Oncol       Date:  2014-03-03       Impact factor: 6.244

9.  Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.

Authors:  Hideki Enokida; Takenari Gotanda; Shoichi Oku; Yoshiharu Imazono; Hiroyuki Kubo; Toshikatsu Hanada; Shigenori Suzuki; Kouhei Inomata; Takao Kishiye; Yoshiyuki Tahara; Kenryu Nishiyama; Masayuki Nakagawa
Journal:  Jpn J Cancer Res       Date:  2002-09

10.  Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoids.

Authors:  Olga Wesołowska; Andrzej B Hendrich; Barbara Łaniapietrzak; Jerzy Wiśniewski; Joseph Molnar; Imre Ocsovszki; Krystyna Michalak
Journal:  Cell Mol Biol Lett       Date:  2008-11-19       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.